Safety and Efficacy of Using Nuts to Improve Bowel Health in Hemodialysis Patients

Autor: Lambert, Kelly ^{∗, ∗}, Bird, Luke, Borst, Addison C. ^∗, Fuller, Andrew ^∗, Wang, Yanan, Rogers, Geraint B., Stanford, Jordan ^∗, Sanderson-Smith, Martina L., Williams, Jonathan G., McWhinney, Brett C. ^∗∗, Neale, Elizabeth P. ^∗, Probst, Yasmine ^∗, Lonergan, Maureen

Publikováno v: In Journal of Renal Nutrition September 2020 30(5):462-469

An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouse

Autor: Kersemans, Veerle, Beech, John S., Gilchrist, Stuart, Kinchesh, Paul, Allen, Philip D., Thompson, James, Gomes, Ana L., D’Costa, Zenobia, Bird, Luke, Tullis, Iain D. C., Newman, Robert G., Corroyer-Dulmont, Aurelien, Falzone, Nadia, Azad, Abul, Vallis, Katherine A., Sansom, Owen J., Muschel, Ruth J., Vojnovic, Borivoj, Hill, Mark A., Fokas, Emmanouil, Smart, Sean C.

Publikováno v: PLoS ONE
PLoS ONE, Public Library of Science, 2017, 12 (4), pp.e0176693. ⟨10.1371/journal.pone.0176693⟩
PLoS ONE, Vol 12, Iss 4, p e0176693 (2017)
PLoS ONE, 2017, 12 (4), pp.e0176693. ⟨10.1371/journal.pone.0176693⟩

Preclinical CT-guided radiotherapy platforms are increasingly used but the CT images are characterized by poor soft tissue contrast. The aim of this study was to develop a robust and accurate method of MRI-guided radiotherapy (MR-IGRT) delivery to ab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::07f010a0ae36f1d7c6c415c43a84d7f7
https://hal-normandie-univ.archives-ouvertes.fr/hal-02042712

CELEBRATING 90 YEARS OF BOOK DESIGN.

Autor: PAYNE, DONNA, BIRD, LUKE, PELHAM, JONATHAN, CROW, ELEANOR

Publikováno v: Computer Arts; May2019, Issue 291, p82-87, 6p, 18 Color Photographs

An efficient and robust MRI-guided radiotherapy planning approach for targeting abdominal organs and tumours in the mouse.

Autor: Kersemans V; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Beech JS; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Gilchrist S; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Kinchesh P; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Allen PD; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Thompson J; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Gomes AL; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., D'Costa Z; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Bird L; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Tullis IDC; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Newman RG; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Corroyer-Dulmont A; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Falzone N; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Azad A; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Vallis KA; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Sansom OJ; Cancer Research UK Beatson Institute, Glasgow, United Kingdom., Muschel RJ; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Vojnovic B; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Hill MA; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom., Fokas E; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom.; Department of Radiotherapy and Oncology, Goethe University Frankfurt, Frankfurt, German.; German Cancer Research Center (DKFZ), Heidelberg, Germany, German Cancer Consortium (DKTK) (Partner Site), Frankfurt, Germany., Smart SC; Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, United Kingdom.

Publikováno v: PloS one [PLoS One] 2017 Apr 28; Vol. 12 (4), pp. e0176693. Date of Electronic Publication: 2017 Apr 28 (Print Publication: 2017).